forum

BIOCON Share Price Discussion

Biocon Ltd.
Sector: Pharmaceuticals and health care
... Read more
BIOCON Share Price *
227.1 -0.75 (-0.33%)
* (quote may be delayed)

BIOCON Discussion Forum


💠💠
HERE IS YOUR FREE EQUITY CALL"
SELL BIOCON AT THE VERY BEGINING
STRICT STRICT STOP LOSS - 231
TARGET - 225/224/222
Disclaimer: All my Views/Suggestions/Calls are for Education Purpose Only. Please consult with your financial adviser before any Trade. All Equity and FNO Trade...
Read more...
Like
reply
Reply
share
Share

BIOCON - 365789

Like
reply
Reply
share
Share

Buy biocon 220 pe cmp3 sl 1.5 target 4,5,6
Like
reply
Reply (2)
share
Share
Latest replies
MARKET SUNRISERS @marketsunrisers
Yesterday 3:21 PM

3.65🔥🔥🔥
MARKET SUNRISERS @marketsunrisers
Yesterday 3:57 PM

Close this

Bye side hold or exit pls tel Seniors
Like
reply
Reply
share
Share
The Inside Guy in BIOCON
*Only for dabba traders* *Sell Biocon fut* c...

Low 229.20 (+4)*1800 RS 7200/- low risk may book,Else wait for more with given SL. 🤫
Like
reply
Reply
share
Share

Bye side hold or exit pls tel Seniors
Like
reply
Reply
share
Share
Yogananda N Naidu in BIOCON
BIOCON 234 WITH +3600 ✅✅

BIOCON 235 WITH +5400 ✅✅✅
Like
reply
Reply
share
Share

BIOCON - chart - 359343
Biocon sep fut 234 Bullish
Like
reply
Reply
share
Share
Yogananda N Naidu in BIOCON
BIOCON 233 WITH +1800 ✅

BIOCON 234 WITH +3600 ✅✅
Like
reply
Reply
share
Share
Yogananda N Naidu in BIOCON
BUY BIOCON ABOVE ⬆️ 232 TGS 235 » 238 » 240 ...

BIOCON 233 WITH +1800 ✅
Like
reply
Reply
share
Share

BUY BIOCON ABOVE ⬆️ 232 TGS 235 » 238 » 240 SL 227
Like
reply
Reply
share
Share

BUY BIOCON ABOVE ⬆️ 232 TGS 235 » 238 » 240 SL 227
Like
reply
Reply
share
Share

*Only for dabba traders*
*Sell Biocon fut* cmp 230-232 SL 240 tgt 222-200 #Holding.
Like
reply
Reply
share
Share

Intra cash sell Biocon @ 232, tgt 223-220, sl dayhigh
Like
reply
Reply (1)
share
Share
Latest replies
Sanjay Gupta @sanjaygupta
Sep 13 8:15 PM

Ye to selling price pe hi ghum raha hai

Buy Biocon above 239 sl 237
Target 241/243/247/251
Like
reply
Reply
share
Share

💎💎💎
YOUR FREE GIFT EQUITY CASH CALL FOR THE DAY!!
BUYBIOCON AT THE VERY BEGINING
STRICT STOP LOSS - 229.85
TARGET - 233/235/237
PLEASE AVOID IF IT OPENS GAP UP MORE THAN 1.5%
Disclaimer: All my Views/Suggestions/Calls are for Education Purpose Only. Please consult with your fi...
Read more...
Like
reply
Reply
share
Share
Stocks in the news: Dr Reddy's Labs, PNB, SBI, PVR, Oriental Bank, DHFL, L&T Finance
Dr Reddy's Labs | PNB | State Bank of India | PVR | Oriental Bank of Commerce | DHFL | L&T Finance Holdings are the stocks which are in news today.
Moneycontrol
Like
reply
Reply
share
Share
Biocon enters into pact with CMS to sell 3 generic products in China
Biocon will be responsible for the development, manufacturing and supply of the products while CMS will be responsible for registration and commercialisation of the products in China.
Moneycontrol
Like
reply
Reply
share
Share
robotrade in BIOCON
Biocon fut buy @231/232 sl 227 Tgt 238💞✋

👆👆👆👆👆
Like
reply
Reply
share
Share

Biocon fut buy @231/232 sl 227
Tgt 238💞✋
1
reply
Reply
share
Share
Trade cautiously, markets will take cue from IIP and CPI numbers
Index of Industrial Production and Consumer Price Index data will be released on September 12.
Moneycontrol
Like
reply
Reply
share
Share

BIOCON - chart - 347942
Biocon weekly chart. Taken support and ready to move upside.
Like
reply
Reply
share
Share
robotech trade in BIOCON
Biocon buy 226/25 Sl 222

236
Like
reply
Reply (3)
share
Share
Latest replies
Sam @shyamala
Sep 7 3:10 AM

Next week it will go up or down?
robotrade @rajivkumarjha
Sep 7 3:15 AM

No idea
I will update on monday morning
More safe buy 233
robotrade @rajivkumarjha
Sep 7 3:16 AM

**OPTION CALL**
**********************
**STOCK**: BIOCON 225 PE @ 5.35
**STOP LOSS:** YOURS
**TARGET:**7.00
**LOT SIZE:** 1800
Like
reply
Reply (2)
share
Share
Latest replies
INTRADAY Options @teamIOFno
Sep 5 7:04 PM

6.15
INTRADAY Options @teamIOFno
Sep 5 8:08 PM

6.20

Buy biocon - 229.6
Sl- below or 228
Tgt- 230.5
Like
reply
Reply (1)
share
Share
Latest replies
Aditya @Aditya007
Sep 4 7:00 PM

230+

BIOCON - 339007
buy biocon option 255ce at 1.6-1.7 target 2.35-3-3.65-4.2-4.95-5.8-6.5 stoploss 1.25 lot size 1800
Like
reply
Reply
share
Share
Global Research in BIOCON
-- POSITIONAL CALL -- BIOCON BUY ABOVE 238 STO...

--IGNORE THIS LEVEL PLEASE--
Like
reply
Reply
share
Share

-- POSITIONAL CALL --
BIOCON BUY ABOVE 238
STOP LOSS - 230
TARGETS - 242 / 246 /250 / 254
Like
reply
Reply
share
Share

BIOCON - 337393

Like
reply
Reply
share
Share
Hustle With Ichimoku in BIOCON
Biocon Sep Future bullish signal

BIOCON - 337179

Like
reply
Reply
share
Share
Hustle With Ichimoku in BIOCON
Biocon Sep Future bullish signal

Biocon Sep Fut. 235.30
buy given at 233 levels
Like
reply
Reply
share
Share
PROFIT CLUB in BIOCON
That day trade executed today😂

234✌️
Like
reply
Reply
share
Share

BIOCON - chart - 335930
Biocon Sep Future bullish signal
Like
reply
Reply
share
Share
PROFIT CLUB in BIOCON
BUY ABOVE 224 SL 222 TARGET 230/233+ INTRA-CASH

That day trade executed today😂
Like
reply
Reply
share
Share

Biocon buy 226/25
Sl 222
Like
reply
Reply
share
Share
Explainer: How Indian pharma companies are riding the biosimilars wave
A Morgan Stanley report says that as many as nine biologic drugs have either gone off patent or will do so by 2025, with combined revenues of $62 billion in 2018.
Moneycontrol
Like
reply
Reply
share
Share
Yogananda N Naidu in BIOCON
BIOCON 💋💋💋226.95 WITH +3600 ✅✅

BIOCON 💋💋💋228 WITH +5400 ✅✅✅
Like
reply
Reply
share
Share
Yogananda N Naidu in BIOCON
BIOCON 226 WITH +1800 ✅

BIOCON 💋💋💋226.95 WITH +3600 ✅✅
Like
reply
Reply
share
Share
Yogananda N Naidu in BIOCON
BUY BIOCON ABOVE ⬆️ 225 TGS 226 » 227 » 228 ...

BIOCON 226 WITH +1800 ✅
Like
reply
Reply
share
Share

BUY BIOCON ABOVE ⬆️ 225 TGS 226 » 227 » 228 UPTO 232 SL 222
Like
reply
Reply
share
Share

BIOCON - chart - 325878
SELL BIOCON FUT AT 230.50 SL 233.50 TARGET 227
Like
reply
Reply
share
Share

Biocon good for long
Like
reply
Reply
share
Share
'Another 5-8% correction still overdue, but HUL, Kotak Bank, HDFC, Nestle can reach new highs'
It should be on priority to add stocks which are beaten down with blue-chip status, visible earnings, good track record and future growth and of course clean books to be added at the present level, Mustafa Nadeem says
Moneycontrol
Like
reply
Reply
share
Share

BIOCON - chart - 325629
BUY ABOVE 224
SL 222
TARGET 230/233+
INTRA-CASH
Like
reply
Reply
share
Share

BIOCON BTST CMP 225 SL 219
Like
reply
Reply (1)
share
Share
Latest replies
Pyramidstock @pyramidstock
Aug 26 2:51 PM

226.20 no major move but still no loss
Rupee at 8-month low; here are 10 stocks that could benefit from the fall in INR
A feeble rupee is not a good sign for the market as it indicates that foreign investors are bearish on the market and exiting their positions
Moneycontrol
Like
reply
Reply
share
Share
Biocon's Malaysia insulins facility gets approval of European drug regulator
The EMA certification will help Biocon secure its supply chain as well as expand sales of its insulin products in European Union nations
Moneycontrol
Like
reply
Reply
share
Share
Temasek, True North and CPPIB in investment talks for stake in Biocon arm: Report
Founded in 2016, Biocon Biologics India (BBIL) is reported to be the fastest-growing division within Biocon, with a 97 percent growth in revenue to Rs 1,516 crore in FY19 compared to FY18.
Moneycontrol
Like
reply
Reply
share
Share
Biocon rises 4% as domestic, foreign firms eye stake in subsidiary
On July 25, Biocon reported an 86 percent year-on-year (YoY) jump in net profit at Rs 223 crore for the quarter ended June.
Moneycontrol
Like
reply
Reply
share
Share
  • BIOCON - Share Price - Fundamentals

    keyboard_arrow_down
    Market Capitalization36,660
    Enterprise Value36,305
    Price to Earnings149.8
    Price to Book Value5.15
    Return on Capital Employed0.04
    Return on Equity0.04
    Face Value5
    Dividend YieldNA
  • BIOCON Share Price - Technicals

    keyboard_arrow_down
    BIOCON - 52 Week High₹718
    BIOCON - 52 Week Low₹211.05
  • BIOCON - Brokerage Reports

    keyboard_arrow_down
    DateBrokerageCallTarget
    2-Aug-19AnandRathiBuy321
    2-Aug-19Axis DirectBuy300
    29-Jul-19Nirmal BangAccumulate257
    26-Jul-19ICICIdirect.comBuy330
    13-Jun-19ICICIdirect.comBuy330
    View all BIOCON - Share Targets - Broker Reports
  • BIOCON Share Price - Historical (₹)

    keyboard_arrow_down
    DateOpenHighLowClose
    Sep 18230.5230.5225.55227.85
    Sep 17231.95234226.3228.05
    Sep 16230.55234.7228.75230.85
    Sep 13237.5237.5230.45232.65
    Sep 12235.75236.85230.05232.2
  • BIOCON Share Price - Daily Moving Averages (DMA)

    keyboard_arrow_down
    20 Day Moving Average₹228.27
    30 Day Moving Average₹227.88
    50 Day Moving Average₹234.4
    100 Day Moving Average₹340.48
    200 Day Moving Average₹484.39
  • BIOCON - Profit And Loss

    keyboard_arrow_down
    CONSOLIDATEDMar-18Mar-17 % Change
    Revenue2,4252,587.9-0.06
    Operating Profit318591.8-0.46
    Profit Before Tax305536.2-0.43
    Net Income238519.3-0.54
  • BIOCON - Balance Sheet

    keyboard_arrow_down
    CONSOLIDATEDMar-19Mar-18 % Change
    Shareholder's Funds7,1156,7370.06
    Total Liabilities1,1251,0450.08
    Total Assets8,2407,7830.06
  • BIOCON - Cash Flow

    keyboard_arrow_down
    CONSOLIDATEDMar-18Mar-17 % Change
    Cash from Operating Activity355185.80.91
    Cash from Investing Activity-553104-6.32
    Cash from Financing Activity-54-238.3-0.77
    Net Cash Flow-25251.5-5.89
  • BIOCON - Ratios

    keyboard_arrow_down
    CONSOLIDATEDMar-18Mar-17
    Return on Assets0.030.07
    Return on Equity0.040.08
    Return on Capital Employed0.040.08
  • BIOCON - 3 year Growth

    keyboard_arrow_down
    3 Year CAGR Growth in Revenue0.08
    3 Year CAGR Growth in Operating Profit-0.22
    3 Year CAGR Growth in EBIDTA-0.21
    3 Year CAGR Growth in Net Income-0.34
    3 Yr CAGR Growth - Diluted EPS-0.78
  • BIOCON - 5 year Growth

    keyboard_arrow_down
    5 Year CAGR Growth in Revenue0.25
    5 Year CAGR Growth in Operating Profit-0.18
    5 Year CAGR Growth in EBIDTANA
    5 Year CAGR Growth in Net Income-0.14
    3 Yr CAGR Growth - Diluted EPS-0.71
  • BIOCON Share Price - Recent News

    keyboard_arrow_down
    NewsBot
    Sep 13 1:48 PM
    Stocks in the news: Dr Reddy's Labs, PNB, SBI, PVR, Oriental Bank, DHFL, L&T Finance
    Moneycontrol
    NewsBot
    Sep 13 1:43 AM
    Biocon enters into pact with CMS to sell 3 generic products in China
    Moneycontrol
    NewsBot
    Sep 10 7:43 PM
    Trade cautiously, markets will take cue from IIP and CPI numbers
    Moneycontrol
    NewsBot
    Aug 28 2:08 AM
    Explainer: How Indian pharma companies are riding the biosimilars wave
    Moneycontrol
    NewsBot
    Aug 25 6:13 PM
    'Another 5-8% correction still overdue, but HUL, Kotak Bank, HDFC, Nestle can reach new highs'
    Moneycontrol
    NewsBot
    Aug 23 3:38 PM
    Rupee at 8-month low; here are 10 stocks that could benefit from the fall in INR
    Moneycontrol
    NewsBot
    Aug 22 5:48 PM
    Biocon's Malaysia insulins facility gets approval of European drug regulator
    Moneycontrol
    NewsBot
    Aug 22 2:38 AM
    Temasek, True North and CPPIB in investment talks for stake in Biocon arm: Report
    Moneycontrol
    NewsBot
    Aug 21 5:48 PM
    Biocon rises 4% as domestic, foreign firms eye stake in subsidiary
    Moneycontrol
    NewsBot
    Aug 2 2:38 AM
    Biocon’s partner Mylan launches first biosimilar of trastuzumab in Australia
    moneycontrol.com
  • BIOCON - Related Communities

    keyboard_arrow_down
    Share and discuss algorithms, strateg...
    Place for new investors to ask questi...
    Help fellow traders de-stress by shar...
    Share and discuss strategies for tax ...
    Want to know more about an upcoming I...
    MCX:MENTHAOIL
    MCX:CPO
    Purpose: Pool and discuss ideas & sug...
    Sector: Index
    Sector: Finance
  • BIOCON - More Information

    keyboard_arrow_down

    Biocon Ltd:
    Biocon Limited is a biopharmaceutical firm in India, engaged in developing, manufacturing and selling pharmaceutical products for oncology, diabetes and autoimmune diseases in the nation as well as abroad. The company has several sectors of operations such as small molecules, branded formulations, research services and more.
    The company is manufacturing insulin lispro, insulin glargine, insulin aspart, recombinant human insulin, monoclonal antibodies, small molecules viz. generic formulations and active pharmaceutical ingredients and more, along with botanical products. Besides that, the company has branded formulation products under brands such as Insugen, BIOMAb, ALZUMAb, EGFR, Basalog and CANMAb. Biocon Limited has certifications such as ISO 9001, ISO 14001:2004, ISO 9001:2000, ISO 15189:2003 and OHSAS 18001:1999. The company has been developing its entire research system based upon small and large molecules, oligonucleotides and antibody-drug conjugates. Clinigene International Ltd and Syngene International Ltd are the two subsidiaries of Biocon Limited. The company has a global intervention in approximately 120 countries.
    About Company Information:
    Biocon Limited was incepted in 1978 and is headquartered in Bangalore, India. Biocon Limited was found when an Indian entrepreneur signed a joint venture with Ireland based firm Biocon Biochemicals Limited in 1978. The company started manufacturing and exporting enzymes to USA and Europe from 1979. Biocon Biochemicals Limited was acquired by Unilever plc and merged with Unilever’s subsidiary Quest International.
    In 1990, the company enhanced its in-house research programme by introducing new technologies. In 1993, the R&D, along with manufacturing facilities of the company, was certified ISO 9001 by RWTUV, Germany. Syngene International Pvt. Ltd was incorporated by the company in 1994 as a Custom Research Company for addressing the exponentially increasing need for outsourced Research & Development in the pharmaceutical sector.
    Developing an efficient manufacturing facility, Biocon Limited started to venture its initiatives for human healthcare in the medicine market and business since 1997. In 1998, Unilever had gone for a deal with ICI for selling its speciality chemicals division, which includes Quest International.
    A totally automated submerged fermentation plant, for the first time in its history of operation, was commissioned by the company in 2000, for manufacturing speciality pharmaceuticals. Clinigene, India’s first Clinical Research Organisation for providing clinical research and development was commissioned by the company in 2000. US FSA approved Biocon Limited as India’s first pharmaceutical company to manufacture the cholesterol-lowering molecule lovastatin.
    In 2005, a commercial agreement was signed by Biocon Limited for supplying insulin API to Asia, Africa and the Middle East. Nation’s largest biotechnology hub, having an integrated set up of manufacturing facilities and research laboratories with a spreading of 90 acres in Karnataka Industrial Areas Development Board—namely, Biocon Park was established by the company in 2006. Country’s largest multi-product Biologics facility was also established at Biocon Park.
    An MoU was signed between Biocon and Neopharma, resulting as a joint venture firm Neobiocon in July 2007. A strategic partnership was established between the company and IATRICa, Inc for developing jointly a range of immunoconjugates regarding the immunotherapy of cancers and infectious diseases in January 2008.
    BASALOG, long-lasting basal insulin for Type 1 & Type 2 Diabetics were introduced by Biocon Limited in 2009. Biocon Cell was launched as the resultant of the partnership between Biocon Limited and ISB for Innovation Management in the same year. AxiCorp GmbH, the German subsidiary of Biocon had been sold by the company in 2011, to its existing promoters and shareholders. ALZUMAb, was launched by Biocon Limited in 2013 for the psoriasis patients in India.
    In 2014, CANMAb – Trastuzumab, a medicine for the treatment of breast cancer was launched by the company in India. A world-class premium devices facility was inaugurated by Biocon at Bangalore in 2015 along with the introduction of Basalog One in India. Mylan and Biocon jointly submitted a proposal for Biosimilar Trastuzumab to USFDA in 2016.
    Biocon Limited declared that along with Mylan it is going to enhance the introduction of adalimumab biosimilar in Europe, as Mylan has an in-licensing arrangement with Fujifilm Kyowa Kirin Biologics.
    How Biocon Ltd, is categorised as a Pharmaceutical and Healthcare Sector, and Pharmaceutical Industry :
    The Pharmaceutical Industry includes companies that derive their business by researching, discovering, developing, manufacturing, and marketing and distributing pharmaceutical medicines and drugs.
    Biocon Ltd is categorized under the Health care sector and Hospitals and Medical services Industry. Healthcare sectors consist of firms involved in the medical space. It is one of the multiple sectors that comprise a range of businesses, including ones that offer medical services directly, or to those that work to develop, create and market medical equipment and medicines. It also includes the other services that provide medical insurance and other related products, and many more.
    The stocks of health care companies mostly have mixed performance. It is due to the inherent challenges to the industry each year, regulatory uncertainties, fiscal policy concerns, and more.
    Biocon Ltd, Competitors and Sector Peers:
    Aarey Drugs & Pharmaceuticals Ltd. AARDRU
    Aarti Drugs Ltd. AARTDR
    Aayush Food & Herbs Ltd. AAYFOO
    Abbott India Ltd. ABBIND
    ABL Bio-Technologies Ltd. ABLBIO
    Addlife Pharma Ltd. ADDPHA
    Advik Laboratories Ltd. ADVLAB
    Ahlcon Parenterals (India) Ltd. AHLPAR
    Ajanta Pharma Ltd. AJAPHL
    Aurobindo Pharma Ltd. AUROBP
    Bharat Immunological & Biologicals Corporation Ltd. BHAIMM
    Biofil Chemicals & Pharmaceuticals Ltd. BIOCHE
    Biowin Pharma (India) Ltd. BIOPHA
    Bliss GVS Pharma Ltd. BLIGVS
    Brabourne Enterprises Ltd.[Amalgamated] RPGLIF
    Brawn Biotech Ltd. BRAPHA
    Brooks Laboratories Ltd. BROLAB
    Cadila Healthcare Ltd. CADHEA
    Caplin Point Laboratories Ltd. CAPPOI
    Cipla Ltd. CIPLTD
    Claris Lifesciences Ltd. CORELA
    Colinz Laboratories Ltd. COLILA
    Combat Drugs Ltd. COMDRU
    Concord Drugs Ltd. CONDRU
    Coral Laboratories Ltd. CORLAB
    Desh Rakshak Aushdhalaya Ltd. DESRAK
    DIL Ltd. DILLIM
    Divi's Laboratories Ltd. DIVIL
    Dolphin Laboratories Ltd. DOLLAB
    Dr. Datsons Labs Ltd. AANLIF
    Dr. Reddy's Laboratories Ltd. DR
    Dujohn Laboratories Ltd. DUJLAB
    Ganga Pharmaceuticals Ltd. GANPHA
    Gennex Laboratories Ltd. GENLAB
    Genomics Biotech Ltd. GENBIO
    GlaxoSmithKline Pharmaceuticals Ltd. GLAPHA
    Glenmark Pharmaceuticals Ltd. GLEPHL
    IOL Chemicals and Pharmaceuticals Ltd. IOLCHE
    Ipca Laboratories Ltd. IPCLAB
    Ishita Drugs & Industries Ltd. ISHDRU
    J B Chemicals & Pharmaceuticals Ltd. JBCH
    Jagsonpal Pharmaceuticals Ltd. JAGPHA
    Jenburkt Pharmaceuticals Ltd. JENPHA
    JK Pharmachem Ltd. JKPHAL
    Jubilant Life Sciences Ltd. JUBILO
    Jupiter Bioscience Ltd. JUPIBI
    Kabra Drugs Ltd. KABDRU
    Kamron Laboratories Ltd. KAMLAB
    Lincoln Pharmaceuticals Ltd. LINPHA
    Lupin Ltd. LUPLTD
    Lyka Labs Ltd. LYKLAB
    Madhuveer Com 18 Network Ltd. TOHPHA
    Mahavir Advanced Remedies Ltd. INDAME
    Makers Laboratories Ltd. MAKLAB
    Mangalam Drugs and Organics Ltd. MANDRU
    New Heaven Chemicals and Industries Ltd. TRAMED
    NGL Fine - Chem Ltd. NGLFIN
    Norris Medicines Ltd. NORMED
    Novartis India Ltd. NOVAIN
    Nutraplus India Ltd. NUTPRO
    Omega Labora.Ltd. OMELAB
    Oriental Remedies & Herbals Ltd. ORIREM
    Ortin Laboratories Ltd. ORTLAB
    Piramal Enterprises Ltd. NICPIR
    Procter & Gamble Health Ltd. MERCLT
    Ranbaxy Laboratories Ltd. RANLAB
    RPG Life Sciences Ltd. RPGLI
    Rubra Medicaments Ltd. RUBMED
    Sanofi India Ltd. AVEPHA
    Sun Pharmaceutical Industries Ltd. SUN28
    Trans Asia Corporation Ltd. TRAASI
    Wockhardt Ltd. WOCLTD
    Wyeth Ltd. WYELTD
    Yogi Healthcare Ltd. COREHE
    Zenith Healthcare Ltd. ZENHEA
    Zenlabs Ethica Ltd. SHRLAK
    Zenotech Laboratories Ltd. ZENLAB
    Zyden Gentec Ltd. ZYDGEN
SOURCE: Data from D'Market via Quandl. Intraday data delayed 15 minutes.
DISCLAIMER: Information is provided "as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.